Sharon Watkins Davis1, Ingrid Oakley-Girvan2,3. 1. Cancer Prevention Institute of California, 2201 Walnut Ave, Ste 300, Fremont, CA, 94538, USA. 2. Cancer Prevention Institute of California, 2201 Walnut Ave, Ste 300, Fremont, CA, 94538, USA. ingrid.oakley-girvan@cpic.org. 3. Department of Health Research and Policy, Stanford Cancer Institute and Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Stanford, CA, 94305, USA. ingrid.oakley-girvan@cpic.org.
Abstract
PURPOSE: This study aimed to identify appropriate development and testing strategies for mobile health applications for cancer survivors. METHODS: In January of 2016, we conducted a PubMed search for mobile applications for cancer survivors. A total of 32 articles were selected for inclusion, including 13 review articles, and 19 articles describing an mHealth application or intervention. We assessed mobile app development and testing strategies and standards as described in these articles. RESULTS: We identified seven elements of patient empowerment applications for cancer survivors, strategies for application development that take advantage of smartphone capabilities, issues for consideration in developing new applications, and steps for creating user-centered mobile health applications that provide meaningful value for cancer survivors. However, few mobile health apps implemented empowerment elements, underwent rigorous design approaches, or included assessment of use in the cancer survivor population. CONCLUSIONS: There is tremendous potential for mobile health apps to benefit cancer survivors. However, there are specific issues for consideration in developing new applications and steps for creating user-centered applications which are not routinely used. This diminishes the value for the cancer survivor population but could be easily addressed through standardized development and testing procedures. IMPLICATIONS FOR CANCER SURVIVORS: Smartphone applications have the potential to improve the cancer survivorship experience, but users should look for evidence that the application was appropriately developed and tested.
PURPOSE: This study aimed to identify appropriate development and testing strategies for mobile health applications for cancer survivors. METHODS: In January of 2016, we conducted a PubMed search for mobile applications for cancer survivors. A total of 32 articles were selected for inclusion, including 13 review articles, and 19 articles describing an mHealth application or intervention. We assessed mobile app development and testing strategies and standards as described in these articles. RESULTS: We identified seven elements of patient empowerment applications for cancer survivors, strategies for application development that take advantage of smartphone capabilities, issues for consideration in developing new applications, and steps for creating user-centered mobile health applications that provide meaningful value for cancer survivors. However, few mobile health apps implemented empowerment elements, underwent rigorous design approaches, or included assessment of use in the cancer survivor population. CONCLUSIONS: There is tremendous potential for mobile health apps to benefit cancer survivors. However, there are specific issues for consideration in developing new applications and steps for creating user-centered applications which are not routinely used. This diminishes the value for the cancer survivor population but could be easily addressed through standardized development and testing procedures. IMPLICATIONS FOR CANCER SURVIVORS: Smartphone applications have the potential to improve the cancer survivorship experience, but users should look for evidence that the application was appropriately developed and tested.
Entities:
Keywords:
Cancer survivorship; Development; Digital technologies; Review; Testing
Authors: Anne Girault; Marie Ferrua; Benoît Lalloué; Claude Sicotte; Aude Fourcade; Fatima Yatim; Guillaume Hébert; Mario Di Palma; Etienne Minvielle Journal: Eur J Cancer Date: 2015-02-04 Impact factor: 9.162
Authors: Ana D Goode; Sheleigh P Lawler; Charlotte L Brakenridge; Marina M Reeves; Elizabeth G Eakin Journal: J Cancer Surviv Date: 2015-03-11 Impact factor: 4.442
Authors: Kelly C Gast; Paul V Viscuse; Somaira Nowsheen; Tufia C Haddad; Robert W Mutter; Andrea E Wahner Hendrickson; Fergus J Couch; Kathryn J Ruddy Journal: Curr Treat Options Cardiovasc Med Date: 2018-03-01
Authors: Alexandra M Psihogios; Yimei Li; Eliana Butler; Jessica Hamilton; Lauren C Daniel; Lamia P Barakat; Christopher P Bonafide; Lisa A Schwartz Journal: JMIR Mhealth Uhealth Date: 2019-04-18 Impact factor: 4.773
Authors: Victoria Ngo; Cynthia G Matsumoto; Jill G Joseph; Janice F Bell; Richard J Bold; Andra Davis; Sarah C Reed; Katherine K Kim Journal: JMIR Mhealth Uhealth Date: 2020-05-26 Impact factor: 4.773
Authors: Ann M Mazzella Ebstein; Margaret Barton-Burke; Venice Anthony; Andrea Smith; Zhigang Zhang; Mark Robson Journal: J Adv Nurs Date: 2020-11-27 Impact factor: 3.187
Authors: Ingrid Oakley-Girvan; Juan M Lavista; Yasamin Miller; Sharon Davis; Carlos Acle; Jeffrey Hancock; Lorene M Nelson Journal: JMIR Form Res Date: 2019-01-11
Authors: Gabriel Ruiz Signorelli; Fedor Lehocki; Matilde Mora Fernández; Gillian O'Neill; Dominic O'Connor; Louise Brennan; Francisco Monteiro-Guerra; Alejandro Rivero-Rodriguez; Santiago Hors-Fraile; Juan Munoz-Penas; Mercè Bonjorn Dalmau; Jorge Mota; Ricardo B Oliveira; Bela Mrinakova; Silvia Putekova; Naiara Muro; Francisco Zambrana; Juan M Garcia-Gomez Journal: J Med Internet Res Date: 2019-10-29 Impact factor: 5.428